Open-label study of alefacept in the treatment of pyoderma gangrenosum

被引:0
|
作者
Feldman, S [1 ]
Jorizzo, JL [1 ]
McCarty, MA [1 ]
机构
[1] Wake Forest Univ, Sch Med, Winston Salem, NC USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:P55 / P55
页数:1
相关论文
共 50 条
  • [1] An open-label pilot study of alefacept for the treatment of pyoderma gangrenosum
    Foss, C. E.
    Clark, A. R.
    Inabinet, R.
    Camacho, F.
    Jorizzo, J. L.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (08) : 943 - 949
  • [2] The use of alefacept for the treatment of Pyoderma gangrenosum
    Feldman, S
    McCarty, A
    Carroll, C
    Willard, J
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB226 - AB226
  • [3] Open-label study of alefacept in the treatment of palmoplandar psoriasis
    Pearce, D
    Feldman, S
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (01) : A7 - A7
  • [4] An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum
    Kontos, A
    Kerr, H
    Fivenson, D
    Remishofsky, C
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P115 - P115
  • [5] An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum
    Kontos, Andrew P.
    Kerr, Holly A.
    Fivenson, David P.
    Remishofsky, Christopher
    Jacobsen, Gordon
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2006, 45 (11) : 1383 - 1385
  • [6] An open-label study evaluating the efficacy and tolerability of alefacept in the treatment of scalp psoriasis
    Krell, James
    Miller, Stephen
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB191 - AB191
  • [7] An open-label study evaluating the efficacy and tolerability of alefacept for the treatment of scalp psoriasis
    Krell, James
    Nelson, Candi
    Spencer, Linda
    Miller, Stephen
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (04) : 609 - 616
  • [8] An open-label study evaluating an extended course of high-dose alefacept for the treatment of psoriasis
    Feldman, S
    McCarty, A
    Carroll, C
    Fleischer, A
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB212 - AB212
  • [9] An open-label community-based study of an extended course of alefacept in the treatment of chronic plaque psoriasis
    Gold, M
    Hamilton, T
    Rynearson, A
    Mathes, B
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P177 - P177
  • [10] Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty-six-week phase 3 open-label study
    Yamasaki, Kenshi
    Yamanaka, Keiichi
    Zhao, Yiwei
    Iwano, Shunsuke
    Takei, Keiko
    Suzuki, Koji
    Yamamoto, Toshiyuki
    [J]. JOURNAL OF DERMATOLOGY, 2020, 47 (12): : 1383 - 1390